Pharmaceutical Commerce Speaks with Herman Sanchez About the Evolving Oncology Market

Partner Herman Sanchez recently spoke with Pharmaceutical Commerce about the cancer market and how immune-oncology is revolutionizing the space. Learn more about the rapidly evolving industry here: http://pharmaceuticalcommerce.com/brand-marketing-communications/new-science-energizes-cancer-market/

Trinity Partners Identifies Value Proposition of Most Expensive Drugs Approved by the FDA from 2014-2016

Trinity Partners today, in tandem with the 22nd Annual International ISPOR Meeting, announced the results of a whitepaper titled, “What We Value: The Proposition Behind the Price.” The authors analyze the costliest drugs to the healthcare system approved by the FDA from 2014-2016 in order to understand the interaction between value and price.  In this industry analysis, Trinity reveals the factors that appear to allow some drugs a higher price point than others and addresses key questions including: What do the most expensive drug launches in the recent past reveal about what our society values? What does the market seem to be willing to pay for?

Download the whitepaper here: http://bit.ly/2qQyKso

Trinity Partners Attends Life Science Cares Impact Breakfast

Trinity team members attended MassBio’s Life Science Cares Impact Breakfast on May 16, celebrating the industry’s commitment to ending poverty in greater Boston with over 500 life science leaders attended the event. Life Science Cares is a collective effort of the life science industry to eliminate the impact of poverty on our neighbors in the greater Boston area. Through uniting the human and financial resources of life science companies and industry leaders, we support service organizations that do the best work in fighting poverty in our community. Check out our team who attended the gathering!

Trinity Partners Experts to Attend Veeva Summit 2017

Trinity Partners, a leading global life sciences consulting firm, announced that John Gillis will attend Veeva Systems’ 2017 Global Commercial & Medical Summit in Philadelphia from May 7-9. Deemed the “industry’s largest event,” our employees are looking forward to networking with over 1,200 life science professionals and learning more about commercial and medical affairs. Read about the conference here: http://bit.ly/1GjpEWp.

Trinity Partners to Present at European Association of Dermato Oncology (EADO)

Trinity Partners, a leading global life sciences consulting firm, announced that Senior Associate Consultant Zahra Al-Khateeb will present a poster from our work with Array BioPharma at the 13th Congress of the EADO in Athens, Greece from May 3-6, 2017. The event will cover all aspects of melanoma and skin cancers, anywhere from epidemiology, diagnosis and prevention to the results of the latest therapeutic trials in advanced tumors. Zahra will present a poster on the current mutation testing approaches in metastatic melanoma and unmet need in the NRAS+ patient population in the U.S. Learn more about the conference: https://www.erasmus.gr/microsites/1063

Consultant Alessandra Moscoso, from our San Francisco office, recently presented to students at Cuesta College’s Edúcate Sí Se Puede Conference on the value of pursuing higher education.

Read the Q&A to learn more about her keynote:

Edúcate Sí Se Puede: A Q&A with Trinity Partners Consultant Alessa Moscoso

Last month, we shared that Consultant Alessandra Moscoso, of Trinity’s San Francisco office, was invited to speak at Cuesta College’s Edúcate Sí Se Puede Conference in San Luis Obispo County, California. Following Alessa’s presentation, we sat down with her to explore her insights on the event, which inspired hundreds of students to see the value of pursuing higher education.

Give us a brief overview of the Edúcate Sí Se Puede and the event’s purpose.

The conference was geared towards Latino/Latina youth and promoted college attendance and the importance of hard work in achieving your dreams. In addition, it communicated the importance of not allowing financial aid to prevent students from attending college. While the event has taken place at Cuesta College for several years, this year was the largest in history and by far the most successful, with 500 students from high schools all over San Luis Obispo county volunteering to be there.

Do you have any ties to the event and organization?

Cuesta College is a part of me. My mother works at the college as an academic counselor; she and my father took classes there when I was growing up. During high school, I also took several courses there.  My mother was part of the planning committee for this conference and one of her co-workers invited me to keynote the event.

What did you and the other speakers discuss with the group?

I presented an overview of my educational and professional journey up until now. I focused on providing the students with three lessons: realizing the value of hard work and how it pays off; remembering to keep your eyes open to unexpected opportunities and always trying new things; and not worrying about planning your entire life, because it will work itself out.

One speaker talked about switching jobs and majors, and how each contributes to your growth. Another highlighted similar themes to mine — working hard and pursuing your passions. While many of our discussions were similar in theme, we all illustrated these themes in different ways. This worked well to demonstrate to the students that not everyone follows the same path to success and that is completely fine.

How did Trinity benefit from your leadership at this event?

Many of the students at the event were not familiar with what, exactly, consulting is. I focused on familiarizing them with the industry and what we do at Trinity, providing exposure to an entirely new career path that many students don’t hear about until college. Looking toward the future, one student could work at Trinity someday due to this conference! Trinity is a huge supporter of education at all levels and we value opportunities like this to educate students on the industry and the options they have as they consider their career paths.

What were your key takeaways from the event?

Before giving my speech, I worried that my words might not inspire the students enough. Following the event, I realized that what they wanted to hear most is my personal narrative. Watching the other speakers, even I wanted to hear about what they had done and felt invested in learning more. Inspiring others is done by sharing your story, so I was lucky to be able to do that.

Participating in this event inspired me to get involved in more events like it. It isn’t the sort of opportunity you’re given all the time. I believe in our future generations and want to make those generations believe in themselves. At Trinity Partners, we are all excited about the future not only of our company but of the healthcare and consulting industries as a whole. Oftentimes, you don’t realize your potential impact until you’re reminded of it through unconventional opportunities like this.

Trinity Client Akcea Therapeutics Publishes Interim Results from Pivotal IN-FOCUS Research Study

Trinity Partners, a leading global life sciences consulting firm, announced that their client, Akcea Therapeutics, a wholly owned subsidiary of Ionis Pharmaceuticals, Inc., has published results from one of the first-ever research studies measuring the considerable burden of patients with familial chylomicronemia syndrome (FCS) and the impact the disease has on their activities of daily living and employment. The results, from an interim analysis of the largest survey in patients with FCS, were published in Expert Review of Cardiovascular Therapy. 

FCS, also known as lipoprotein lipase deficiency (LPLD) or type I hyperlipoproteinemia, is a rare genetic disease characterized by extremely high levels of triglycerides and increased risk of other health complications, including pancreatitis. IN-FOCUS, a comprehensive web-based research survey of patients with FCS, was designed to capture the associated burden of illness and impact on quality of life. Sixty patients from the United States diagnosed with FCS participated; patients described multiple symptoms spanning across physical, emotional and cognitive domains.

An analysis of the survey data found that patients with FCS saw five physicians on average with FCS-related symptoms before receiving a proper diagnosis. Nearly all respondents reported frequent, debilitating symptoms leading to reduced quality of life. Respondents also indicated that FCS significantly influenced their career choice and employment status, and resulted in substantial work loss.

Learn more about the study results: http://bit.ly/2oNlzbE

Read Endocrine Today’s article on the findings: http://bit.ly/2oaDxDE